Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DeathXray33on Apr 20, 2024 8:12pm
139 Views
Post# 35999851

RE:RE:What price could Theralase fetch ?

RE:RE:What price could Theralase fetch ?
StevenBirch wrote: Some people laughed at projections of $20, being 16 cents and all right now, but it won't go from 16 cents to $20 and that's why BTD is the important first step. That should send it somewhere into the dollars, maybe $2 maybe $3? But that will allow them to fund the next stage of their development, GBM is up first it seems but there are many others. Maybe when data starts coming in on GBM it gets another boost, maybe $7 or $10? Then when some of the other trials start that's when being bought out becomes a possibility. It all depends on them being successful each step along the way starting with first getting BTD but if they are successful then $20 will look like 16 cents does now - rock bottom!

The dum dums on ignore won't like that positivity but if I didn't feel that way I would have sold long ago.


BTD for each indication.
<< Previous
Bullboard Posts
Next >>